Cardio-Vascular Interventions in the Elderly
(organised by the Acquired Cardiac Disease Domain in collaboration with EACTA, ESC, EuroPCR)
Session 1: Coronary revascularisation in the elderly
Moderator: P Kolh, Liege; W Wijns, Leuven
| 08:00 | Epidemiology and natural life expectancy in elderly patients suffering from cardiovascular disease | U Kunze, Vienna |
| 08:20 | Are there any exceptions to the use of total arterial grafting in elderly patients? | B Buxton, Victoria |
| 08:40 | There is no limitation to total arterial grafting in coronary surgery | D Taggart, Oxford |
| 09:00 | Health-Related quality of life after cardiac surgery in the elderly patient: what does it mean? | T Athanasiou, London |
| 09:20 | Quality adjusted life years PCI versus CABG | A P Kappetein, Rotterdam |
| 09:40 | Cardiac cell therapy: a realistic concept for elderly patients? | M Siepe, Freiburg |
| 10:00 | Coffee |
Session 2: Managing Octogenarians with aortic valvular heart disease
Moderator: A Franco-Cereceda, Stockholm; M Czerny, Vienna
| 10:20 | Patho-Physiology of the old heart and implications for cardiac surgery | P Kolh, Liege |
| 10:40 | It is time for a randomised tiral of transcatheter versus surgical aortic valve implantation. Inclusion and exclusion criteria | TBA |
| 11:00 | Results of surgery in octogenarians: UK registry | L Hamilton, Newcastle-upon-Tyne |
| 11:20 | Managing octogenarian patients with valvular heart disease from the outpatient clinic to intervention. Difficult to measure functional reserves | M Köller, Vienna |
| 11:40 | Tailoring the drugs in the elderly | A Rajek, Vienna |
| 12:00 | Lunch |
The Great Debate: Treating Elderly Patients
Moderator: J Fajadet, Toulouse
| 12:30 | Introduction | J Marco |
| P Kala | ||
| K Niemela | ||
| J L Pomar, Barcelona | ||
| G Wimmer-Greinecker, Bad Bevensen | ||
| M Thompson |
Session 3: Managing Octogenarians with Mitral Valvular Disease
Moderators: J Pomar, Barcelona; A Vahanian, Paris
| 13:45 | Asymptomatic Mitral Valve insufficiency does age influence the therapeutic decision? | R Rosenhek, Vienna |
| 14:05 | Operating theatre: organ protection in the elderly | M Rannuci, Milan |
| 14:25 | Should all mitral valve operations in the elderly be done minimally invasive? | J Seeburger, Leipzig |
| 14:45 | Left venticular dysfunction and mitral valve insufficiency. Does age influence the therapeutic decision? | O Alfieri, Milan |
| 15:05 | Arrhythmia surgery in the elderly, sense or non-sense | TBA |
| 15:25 | Is mitral valve repair superior to replacement in elderly patients? | S Nashef, Papworth |
| 15:45 | Surgery for tricuspid regurgitation late after mitral valve replacement or repair | M De Bonis, Milan |
Session 4: Pathology of the aorta in the elderly
Moderators:
| 16:05 | Aortic pathology: medical treatment. Natural course of aortic disease in the elderly | H Eggebrecht, Vienna |
| 16:25 | Beyond the pericardium: Extracardiac physiology in elderly patients | P Fasching, Vienna |
| 16:45 | The benefits of interventional treatment in the elderly | M Grimm, Vienna |
| 17:05 | Adjourn |
PROGRAMME SUBJECT TO CHANGE
SPONSORED BY ST JUDE MEDICAL